EFTA00489768.pdf
PDF Source (No Download)
Extracted Text (OCR)
From: Richard Kahn
To: EM
IES
Subject: Re:
Date: Thu, 17 Jan 2019 22:20:11 +0000
i asked JEE and he said to ignore so no need to follow up with jee..
thanks
Richard Kahn
ew or
tel
fax
cell
On Jan 17, 2019, at 4:04 PM,
Thx
Sent from my iPhone
On Jan 17, 2019, at 3:50 PM, Richard Kahn <
i will mention to jee when we speak next
thanks
Richard Kahn
HBRK Associates Inc.
575 Lexington Avenue 4th Floor
New York, NY 10022
tel
fax
cell
On Jan 17, 2019, at 12:19 PM,
> wrote:
> wrote:
> wrote:
Christina requested I forward you the below `catch up' email.
EFTA00489768
SioHebe
cell:
email:
www.Mohebe.com
@Bioliebe
<1506365439123blobjpg>
Fro
To:
Sent: Wednesday, January 16, 2019, 11:22:06 PM EST
Subject: Catching Up
Dear Jeffrey
I hope you've been well. I wanted to update you on what I've been up to for the last two years. I was also
hoping to talk with you to see if I might use the foundation's Lexington office conference room from time
to time for my work and what I could provide in exchange for that. I am cc'ing Rich because I'm not sure if
you still use this email?
Since working for your foundation, I continued to publish as a joumalist writing mostly about genetic
vectors (Newsweek, Tethonomy etc). I then set up an LLC that provides business development for labs that
have reversed age-driven or degenerative diseases. Most of the therapies are genetic vectors, and have to
show remarkable results at the mouse level and beyond. Regenerative medicine is a rapidly evolving field,
and one that forces the medical industry to shift their focus from addressing symptoms of disease to
fundamental evolutionary shortfalls.
So far, I placed a genetic vector at the National Institute of Medicine in France (that reversed glaucoma in
mice using the neuroglobin gene) under formal licence review with a publicly traded pharma group here in
the US. And I am collaborating with a lab at the University of Pittsburgh that has reversed cirrhosis/ end
stage liver disease in rats using the master transcription gene in hepatocytes. The concept of the latter
gene vector is really intriguing in that a master transcription gene completely restored liver function by
rebalancing genetic expression and thus proteostasis.
While I don't really need an office at this point, I do need access to a conference room from time to time
and it would be hugely helpful if I could access the foundation's. If there was some work that I could do
for the foundation in exchange, I would be delighted to do that.
It would be wonderful to catch up with you as well.
all the best,
EFTA00489769
cell:
cmail
Www.biohebe.com
0]BioHebe
<1506365439123blobjpg>
<I 506365439123blobjpr< I 506365439123blobjpg>
EFTA00489770
Document Preview
PDF source document
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
This document was extracted from a PDF. No image preview is available. The OCR text is shown on the left.
Extracted Information
Document Details
| Filename | EFTA00489768.pdf |
| File Size | 101.3 KB |
| OCR Confidence | 85.0% |
| Has Readable Text | Yes |
| Text Length | 2,761 characters |
| Indexed | 2026-02-11T22:14:38.622487 |